Wondering if anyone out there is holding it, it just had a reverse 10to1 and made a lot of leadership changes to go from r&d to commercialization by eoy for their multiple sclerosis medication as their phase 3 comes to an end. Also saw a few big opens by hedge funds ie rockefeller holdings. Everything looking good for a buyout and just overall imo. Was wondering what others are thinking about it?